» Articles » PMID: 26973957

Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients

Overview
Date 2016 Mar 15
PMID 26973957
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Depression is a mental disorder with a high prevalence among patients with end stage renal disease (ESRD). It is reported that depression afflicts approximately 20-30% of this patient population, being associated, amongst other, with high mortality rate, low adherence to medication and low perceived quality of life. There is a variety of medications known to be effective for the treatment of depression but due to poor adherence to treatment as well as due to the high need for medications addressing other ESRD comorbidities, depression often remains untreated. According to the literature, depression is under-diagnosed and undertreated in the majority of the patients with chronic kidney disease. In the current review the main pharmacological and non-pharmacological approaches and research outcomes for the management of depressive symptoms in hemodialysis patients are discussed.

Citing Articles

Effects of exercise dose based on the ACSM recommendations on depression in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials.

Fang Y, Xiaoling B, Huan L, Yaping G, Binying Z, Man W Front Physiol. 2025; 15:1513746.

PMID: 39959813 PMC: 11825786. DOI: 10.3389/fphys.2024.1513746.


The effect of recreational therapy application on depression in hemodialysis patients: a randomized clinical trial.

Alishahi M, Mohajer S, Namazinia M, Mazloum S Int Urol Nephrol. 2024; 57(2):585-594.

PMID: 39259395 DOI: 10.1007/s11255-024-04201-7.


Depression Among Hemodialysis Patients: Related Factors and the Impact of Insomnia and Fatigue.

Sakiqi J, Vasilopoulos G, Koutelekos I, Polikandrioti M, Dousis E, Pavlatou N Cureus. 2022; 14(5):e25254.

PMID: 35755568 PMC: 9217109. DOI: 10.7759/cureus.25254.


Influence of Depression and Anxiety on Hemodialysis Patients: The Value of Multidisciplinary Care.

Delgado-Dominguez C, Sanz-Gomez S, Lopez-Herradon A, Diaz Espejo B, Lamas Gonzalez O, de Los Santos Roig M Int J Environ Res Public Health. 2021; 18(7).

PMID: 33805492 PMC: 8036719. DOI: 10.3390/ijerph18073544.


Management of anxiety and depression in haemodialysis patients: the role of non-pharmacological methods.

Gerogianni G, Babatsikou F, Polikandrioti M, Grapsa E Int Urol Nephrol. 2018; 51(1):113-118.

PMID: 30456545 DOI: 10.1007/s11255-018-2022-7.


References
1.
Kimmel P . Psychosocial factors in dialysis patients. Kidney Int. 2001; 59(4):1599-613. DOI: 10.1046/j.1523-1755.2001.0590041599.x. View

2.
Theofilou P . Medication adherence in Greek hemodialysis patients: the contribution of depression and health cognitions. Int J Behav Med. 2012; 20(2):311-8. DOI: 10.1007/s12529-012-9231-8. View

3.
Kessler R, Berglund P, Demler O, Jin R, Koretz D, Merikangas K . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289(23):3095-105. DOI: 10.1001/jama.289.23.3095. View

4.
Kimmel P, Peterson R . Depression in patients with end-stage renal disease treated with dialysis: has the time to treat arrived?. Clin J Am Soc Nephrol. 2007; 1(3):349-52. DOI: 10.2215/CJN.00890306. View

5.
Drayer R, Mulsant B, Lenze E, Rollman B, Dew M, Kelleher K . Somatic symptoms of depression in elderly patients with medical comorbidities. Int J Geriatr Psychiatry. 2005; 20(10):973-82. DOI: 10.1002/gps.1389. View